ARTICLE | Clinical News
Fycompa perampanel regulatory update
October 29, 2012 7:00 AM UTC
FDA approved epilepsy drug Fycompa perampanel from Eisai as adjunct treatment for partial onset seizures in patients with epilepsy ages >=12 years. The pharma will announce a launch timeline for Fycom...